240P Molecular drivers and temporal patterns of recurrence after R0 in non-small cell lung cancer: EGFR- and ALK-specific insights from the GECP thoracic tumour registry

Molecular alterations are an important factor when addressing treatment and may also influence the timing and risk of recurrence after complete (R0) resection in NSCLC. This study aimed to characterise recurrence-free survival (RFS) and recurrence dynamics in patients with EGFR-mutated and ALK-rearranged tumours.

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2026-03-17
DOI
https://doi.org/10.1016/j.esmoop.2026.106548
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

240P Molecular drivers and temporal patterns of recurrence after R0 in non-small cell lung cancer: EGFR- and ALK-specific insights from the GECP thoracic tumour registry

María‐Victoria Mateos, Óscar Vidal, J.M. Oramas Rodriguez, J.L. Fírvida Pérez et al.
ESMO Open
Lung Cancer Treatments and Mutations
article

240P Molecular drivers and temporal patterns of recurrence after R0 in non-small cell lung cancer: EGFR- and ALK-specific insights from the GECP thoracic tumour registry

María‐Victoria Mateos, Óscar Vidal, J.M. Oramas Rodriguez, J.L. Fírvida Pérez, P. Soto Rojas, J. Bosch Barrera, A. Cantero, A.L.O. Ortega Granados, S. Cerezo Gonzalez, R. Aguado, D. Aguiar Bujanda, M. Domine Gomez, M.A. Cobo Dols, R. López Castro, M. Cucurull Salamero, P. Espinosa Olarte, M. Provencio Pulla, B. Massuti Sureda, A. Sanchez Hernandez, I. Morilla Ruiz
article en

Abstract

Molecular alterations are an important factor when addressing treatment and may also influence the timing and risk of recurrence after complete (R0) resection in NSCLC. This study aimed to characterise recurrence-free survival (RFS) and recurrence dynamics in patients with EGFR-mutated and ALK-rearranged tumours.

ESMO OpenVol. 11
Hospital Universitario Insular de Gran Canaria (ES), Hospital Universitario de Canarias (ES), Hospital Clínico San Carlos (ES), Hospital Universitari i Politècnic La Fe (ES), Clínica Girona (ES), Consorcio Hospitalario Provincial de Castellón (ES), Complejo Hospitalario de Navarra (ES), Hospital Universitario de Gran Canaria Doctor Negrín (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Institut Català d'Oncologia (ES), Hospital Regional Universitario de Málaga (ES), Complejo Hospitalario de Jaén (ES), Hospital General Universitario De Valencia (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Hospital General Universitario de Alicante Doctor Balmis (ES), Hospital Clínico Universitario de Valladolid (ES), Complejo Hospitalario de Ourense (ES)
Good health and well-being
Openalex Percentile: Top 20%
Lung Cancer Treatments and Mutations
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.